[HTML][HTML] MYC as a target for cancer treatment

MJ Duffy, S O'Grady, M Tang, J Crown - Cancer treatment reviews, 2021 - Elsevier
The MYC gene which consists of 3 paralogs, C-MYC, N-MYC and L-MYC, is one of the most
frequently deregulated driver genes in human cancer. Because of its high prevalence of …

Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments

U Testa, G Castelli, E Pelosi - Medical Sciences, 2020 - mdpi.com
Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …

Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data

D Sun, X Guan, AE Moran, LY Wu, DZ Qian… - Nature …, 2022 - nature.com
Single-cell RNA sequencing (scRNA-seq) distinguishes cell types, states and lineages
within the context of heterogeneous tissues. However, current single-cell data cannot …

Cancer stem cell plasticity–a deadly deal

AP Thankamony, K Saxena, R Murali… - Frontiers in molecular …, 2020 - frontiersin.org
Intratumoral heterogeneity is a major ongoing challenge in the effective therapeutic targeting
of cancer. Accumulating evidence suggests that a fraction of cells within a tumor termed …

[HTML][HTML] Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer

EH Ervin, R French, CH Chang, S Pauklin - Seminars in cancer biology, 2022 - Elsevier
Cell identity is largely determined by its transcriptional profile. In tumour, deregulation of
transcription factor expression and/or activity enables cancer cell to acquire a stem-like state …

Multi-transcriptome analysis following an acute skeletal muscle growth stimulus yields tools for discerning global and MYC regulatory networks

KA Murach, Z Liu, B Jude, VC Figueiredo, Y Wen… - Journal of Biological …, 2022 - ASBMB
Myc is a powerful transcription factor implicated in epigenetic reprogramming, cellular
plasticity, and rapid growth as well as tumorigenesis. Cancer in skeletal muscle is extremely …

Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus

Z Nehme, S Pasquereau, SH Ahmad, R El Baba… - …, 2022 - thelancet.com
Background Human cytomegalovirus (HCMV) infection has been actively implicated in
complex neoplastic processes. Beyond oncomodulation, the molecular mechanisms that …

The inhibitory mechanisms of tumor PD-L1 expression by natural bioactive gallic acid in non-small-cell lung cancer (NSCLC) cells

DY Kang, N Sp, ES Jo, A Rugamba, DY Hong, HG Lee… - Cancers, 2020 - mdpi.com
Non-small-cell lung cancer (NSCLC) is the most common lung cancer subtype and accounts
for more than 80% of all lung cancer cases. Epidermal growth factor receptor (EGFR) …

DOT1L is a novel cancer stem cell target for triple-negative breast cancer

H Kurani, SF Razavipour, KB Harikumar… - Clinical cancer …, 2022 - AACR
Purpose: Although chemotherapies kill most cancer cells, stem cell–enriched survivors seed
metastasis, particularly in triple-negative breast cancers (TNBC). TNBCs arise from and are …

Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapy

PP Praharaj, DP Panigrahi, CS Bhol, S Patra… - Cancer Letters, 2021 - Elsevier
Cancer stem cells (CSCs) are distinct subpopulations of cancer cells with stem cell-like
abilities and are more resilient to chemotherapy, causing tumor relapse. Mitophagy, a …